Cetuximab

Common brands: Erbitux, Efudex, Fluorouracil, Tolak, Oxaliplatin

Top reporter: Imclone Llc

Epidermal Growth Factor Receptor Antagonist [EPC]Platinum-based Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]Microtubule Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]
30,786
Total Reports
9,631
Serious Reports
4,188
Death Reports
30
Reported Reactions
Death Report Ratio: High (13.60%)

Patient Demographics

Male
17,439
Female
8,829

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cetuximab.

# Reaction Reports % of Total
1 RASH 2,256
7.4%
2 DIARRHOEA 2,003
6.6%
3 OFF LABEL USE 1,854
6.1%
4 NAUSEA 1,633
5.3%
5 VOMITING 1,381
4.5%
6 DYSPNOEA 1,375
4.5%
7 NEUTROPENIA 1,213
4.0%
8 PYREXIA 1,118
3.7%
9 DEHYDRATION 1,103
3.6%
10 INFUSION RELATED REACTION 1,098
3.6%
11 MALIGNANT NEOPLASM PROGRESSION 1,083
3.5%
12 DEATH 1,064
3.5%
13 FATIGUE 1,062
3.5%
14 HYPOTENSION 919
3.0%
15 ANAEMIA 913
3.0%
16 DECREASED APPETITE 859
2.8%
17 DERMATITIS ACNEIFORM 850
2.8%
18 ASTHENIA 834
2.7%
19 MUCOSAL INFLAMMATION 823
2.7%
20 WHITE BLOOD CELL COUNT DECREASED 729
2.4%
21 THROMBOCYTOPENIA 715
2.3%
22 PRURITUS 685
2.2%
23 WEIGHT DECREASED 674
2.2%
24 STOMATITIS 667
2.2%
25 PNEUMONIA 644
2.1%
26 HYPERSENSITIVITY 629
2.1%
27 HYPOMAGNESAEMIA 593
1.9%
28 FEBRILE NEUTROPENIA 588
1.9%
29 DISEASE PROGRESSION 583
1.9%
30 MYELOSUPPRESSION 582
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.